@article{fdi:010070158,
  title = {{Q}uassia "biopiracy" case and the {N}agoya {P}rotocol : a researcher's perpective},
  author = {{B}ourdy, {G}enevi{\`e}ve and {A}ubertin, {C}atherine and {J}ullian, {V}al{\'e}rie and {D}eharo, {E}ric},
  editor = {},
  language = {{ENG}},
  abstract = {{B}iopiracy accusations are common in the world of biodiversity research. {A}t the end of 2015, a {F}rench {NGO} accused researchers from the {I}nstitut de {R}echerche pour le {D}{\'e}veloppement ({IRD}) of biopiracy. {T}hese researchers had applied for a patent for a natural bioactive molecule against malaria and cancer, the {S}imalikalactone {E}, isolated from {Q}uassia amara {L}. ({S}imaroubaceae) leaves. {T}his biopiracy allegation triggered a huge wave of attacks from the media and social networks, and vehement recrimination from political officials in {F}rench {G}uiana against researchers who have been accused of ethical misconduct, by stealing the traditional knowledge of indigenous people. {T}hese accusations were made in the contentious context of the ratification of the {N}agoya {P}rotocol in the frame of implementing the {F}rench law on biodiversity, nature and landscapes. {S}o, in an atmosphere of heightened emotions it is crucial to understand the issues behind these accusations. {W}e describe herein the genesis of our discovery, present the detractors' arguments, and discuss the consequences of such biopiracy denunciations for scientific research. {W}e also address our concerns about the gap between rhetoric and reality and the real impact of the {N}agoya {P}rotocol on biodiversity conservation.},
  keywords = {{GUYANE} {FRANCAISE}},
  booktitle = {},
  journal = {{J}ournal of {E}thnopharmacology},
  volume = {4},
  numero = {4},
  pages = {290--297},
  ISSN = {0378-8741},
  year = {2017},
  DOI = {10.1016/j.jep.2017.05.030},
  URL = {https://www.documentation.ird.fr/hor/fdi:010070158},
}